Meredith Giuliani – författare

First-of-its-kind resource exploring how cancer care fits into a general health system, contributed to by internationally eminent interdisciplinary experts

Cancer Systems and Control for Health Professionals delivers a comprehensive overview of the subject of cancer control, cancer services and systems organization and performance, principles of care delivery, cancer policy and social issues. Its distinguishing feature lies in its systematic exploration of cancer through a holistic lens, emphasizing systems-level understanding and the application of cancer control theory principles to address its complexities.

Through this holistic lens, readers are invited to appreciate the complex interactions of patients, caregivers, cancer biology, health policy, politics and health human resources. Readers will find strategies to reduce the incidence, morbidity, and mortality of cancer and to improve the quality of life through the implementation of prevention, early detection, diagnosis, treatment, and supportive and palliative care in a population.

Throughout the text, examples are given of how understanding different cancer control ecosystems can improve engagement in various parts of the world.

With contributions by global experts in the field with diverse backgrounds in education, technology, public health, health policy, and advocacy, Cancer Systems and Control for Health Professionals explore diverse topics including:

Cancer Systems and Control for Health Professionals is a timely, forward-thinking resource on the subject for oncologists, cancer professionals and researchers, public health professionals and researchers, and cancer control experts, along with students in related programs of study.

First-of-its-kind resource exploring how cancer care fits into a general health system, contributed to by internationally eminent interdisciplinary experts

Cancer Systems and Control for Health Professionals delivers a comprehensive overview of the subject of cancer control, cancer services and systems organization and performance, principles of care delivery, cancer policy and social issues. Its distinguishing feature lies in its systematic exploration of cancer through a holistic lens, emphasizing systems-level understanding and the application of cancer control theory principles to address its complexities.

Through this holistic lens, readers are invited to appreciate the complex interactions of patients, caregivers, cancer biology, health policy, politics and health human resources. Readers will find strategies to reduce the incidence, morbidity, and mortality of cancer and to improve the quality of life through the implementation of prevention, early detection, diagnosis, treatment, and supportive and palliative care in a population.

Throughout the text, examples are given of how understanding different cancer control ecosystems can improve engagement in various parts of the world.

With contributions by global experts in the field with diverse backgrounds in education, technology, public health, health policy, and advocacy, Cancer Systems and Control for Health Professionals explore diverse topics including:

Cancer Systems and Control for Health Professionals is a timely, forward-thinking resource on the subject for oncologists, cancer professionals and researchers, public health professionals and researchers, and cancer control experts, along with students in related programs of study.

The essential reference on cancer stage returns as a fully revised edition

Describing cancer stage is one of the most important elements of oncological practice. Clinical research and clinical care depend on an accurate assessment of cancer stage and prognostic factors. The TNM Classification of Malignant Tumours serves as the globally recognised standard reference for describing cancer stage and assessing treatment results. Now fully updated to reflect the results of the latest clinical research, it is indispensable for all clinicians, cancer registrars and researchers who work with malignant tumours.

Readers of the ninth edition of TNM Classification of Malignant Tumours will find:

TNM Classification of Malignant Tumours is an essential resource for anyone involved in cancer care, research or cancer control.

The essential reference on cancer stage returns as a fully revised edition

Describing cancer stage is one of the most important elements of oncological practice. Clinical research and clinical care depend on an accurate assessment of cancer stage and prognostic factors. The TNM Classification of Malignant Tumours serves as the globally recognised standard reference for describing cancer stage and assessing treatment results. Now fully updated to reflect the results of the latest clinical research, it is indispensable for all clinicians, cancer registrars and researchers who work with malignant tumours.

Readers of the ninth edition of TNM Classification of Malignant Tumours will find:

TNM Classification of Malignant Tumours is an essential resource for anyone involved in cancer care, research or cancer control.

Die TNM-Klassifikation ist das weltweit am häufigsten verwendete System für die Beschreibung der anatomischen Ausbreitung maligner Tumoren mit Unterscheidung eines klinischen und eines pathologischen Teils. Die Klassifikation wird in Zusammenarbeit mit der Union for International Cancer Control (UICC) herausgegeben und umfasst im Wesentlichen alle anatomischen Regionen gemäß den WHO-Richtlinien (WHO-Richtlinien zur Klassifikation der Krankheiten für die Onkologie (ICD-O)). Die Beschreibung jeder Region umfasst die klinischen sowie die pathologischen Kriterien für die Bestimmung der T-, N- und M-Kategorien, die Abgrenzung der anatomischen Bezirke bzw. Unterbezirke, eine Definition der regionären Lymphknoten, das histopathologische Grading sowie eine Stadiengruppierung.

Die 9. Auflage dokumentiert lückenlos die aktuellen Definitionen der TNM-Tumorklassifikation. Basierend auf neuen Daten zur Prognose und neuen Methoden zur Bestimmung des Tumorgrads wurden einige Tumorentitäten und anatomische Lokalisationen neu eingeführt, bei anderen wurden Modifikationen vorgenommen. Erstmals werden nun auch Tumoren des Gehirns, des Rückenmarks, der Nebenschilddrüsen sowie des Nebennierenmarks klassifiziert.